Published in J Clin Hypertens (Greenwich) on December 17, 2013
Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses. BMJ (2016) 1.30
Personalized therapeutics of α₁-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Clin Interv Aging (2015) 1.07
Lipid, blood pressure and kidney update 2013. Int Urol Nephrol (2014) 1.05
Racial/ethnic differences in hypertension prevalence, treatment, and control for outpatients in northern California 2010-2012. Am J Hypertens (2014) 0.95
Identifying Individuals at Risk for Cardiovascular Events Across the Spectrum of Blood Pressure Levels. J Am Heart Assoc (2015) 0.94
Documented lifestyle education among young adults with incident hypertension. J Gen Intern Med (2014) 0.91
A lot of primary arterial hypertensions. Only one blood pressure therapeutic target? Maedica (Buchar) (2014) 0.88
Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome (2017) 0.87
Acute hypertension: a systematic review and appraisal of guidelines. Ochsner J (2014) 0.84
Hypertension and mortality in the Golestan Cohort Study: A prospective study of 50 000 adults in Iran. J Hum Hypertens (2015) 0.83
Management of hypertension in CKD: beyond the guidelines. Adv Chronic Kidney Dis (2015) 0.83
Alternative Medications for Medications in the Use of High-Risk Medications in the Elderly and Potentially Harmful Drug-Disease Interactions in the Elderly Quality Measures. J Am Geriatr Soc (2015) 0.82
BP Control and Long-Term Risk of ESRD and Mortality. J Am Soc Nephrol (2016) 0.81
Efficacy and Safety of a Traditional Chinese Herbal Formula Xuefu Zhuyu Decoction for Hypertension: A Systematic Review and Meta-Analysis. Medicine (Baltimore) (2015) 0.81
A Review of Nebivolol Pharmacology and Clinical Evidence. Drugs (2015) 0.81
Missed Opportunities to Address Cardiovascular Disease Risk Factors amongst Adults Attending an Urban HIV Clinic in South Africa. PLoS One (2015) 0.81
A Network Meta-Analysis of Clinical Management Strategies for Treatment-Resistant Hypertension: Making Optimal Use of the Evidence. J Gen Intern Med (2017) 0.81
Effects of azilsartan medoxomil compared with olmesartan and valsartan on ambulatory and clinic blood pressure in patients with type 2 diabetes and prediabetes. J Hypertens (2016) 0.80
Key Points of the Japanese Society of Hypertension Guidelines for the Management of Hypertension in 2014. Pulse (Basel) (2015) 0.80
Achieving Weight Loss and Hypertension Control Among Obese Adults: A US Multidisciplinary Group Practice Observational Study. Am J Hypertens (2016) 0.80
Effect of tea theaflavins and catechins on microvascular function. Nutrients (2014) 0.80
The comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases. Drug Saf (2015) 0.80
Combination therapy of renin-angiotensin system inhibitors plus calcium channel blockers versus other two-drug combinations for hypertension: a systematic review and meta-analysis. J Hum Hypertens (2016) 0.79
Effects of eight weeks of aerobic interval training and of isoinertial resistance training on risk factors of cardiometabolic diseases and exercise capacity in healthy elderly subjects. Oncotarget (2015) 0.79
"I have to live like I'm old." Young adults' perspectives on managing hypertension: a multi-center qualitative study. BMC Fam Pract (2016) 0.79
Hypertension in populations of different ethnic origins. Lancet (2014) 0.79
Increasing complexity: which drug class to choose for treatment of hypertension in the elderly? Clin Interv Aging (2014) 0.79
Target organ complications and prognostic significance of alerting reaction: analysis from the Dallas Heart Study. J Hypertens (2016) 0.78
Patients with undiagnosed hypertension: hiding in plain sight. JAMA (2014) 0.78
Treatment of Hypertensive Patients with a Fixed-Dose Combination of Bisoprolol and Amlodipine: Results of a Cohort study with More Than 10,000 Patients. Cardiol Ther (2015) 0.78
Nephroprevention in the oldest old with chronic kidney disease: Special considerations. World J Nephrol (2015) 0.78
Towards Investigating Global Warming Impact on Human Health Using Derivatives of Photoplethysmogram Signals. Int J Environ Res Public Health (2015) 0.77
Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups. Vasc Health Risk Manag (2015) 0.77
High Blood Pressure and All-Cause and Cardiovascular Disease Mortalities in Community-Dwelling Older Adults. Medicine (Baltimore) (2015) 0.77
Towards better hypertension management in India. Indian J Med Res (2014) 0.77
Improved Blood Pressure Control to Reduce Cardiovascular Disease Morbidity and Mortality: The Standardized Hypertension Treatment and Prevention Project. J Clin Hypertens (Greenwich) (2016) 0.76
Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill. Curr Hypertens Rep (2016) 0.76
Impact of Flavonols on Cardiometabolic Biomarkers: A Meta-Analysis of Randomized Controlled Human Trials to Explore the Role of Inter-Individual Variability. Nutrients (2017) 0.75
Cardiovascular disease risk by assigned treatment using the 2013 and 1998 obesity guidelines. Obesity (Silver Spring) (2016) 0.75
Current Practice of Hypertension in India: Focus on Blood Pressure Goals. J Clin Diagn Res (2016) 0.75
MyHEART: A Non Randomized Feasibility Study of a Young Adult Hypertension Intervention. J Hypertens Manag (2016) 0.75
Missed Opportunities to Improve the Health of Postpartum Women: High Rates of Untreated Hypertension in Rural Tanzania. Matern Child Health J (2017) 0.75
Prevalence of and factors related to mild and substantial dizziness in community-dwelling older adults: a cross-sectional study. BMC Geriatr (2016) 0.75
The association between Self-Reported Medication Adherence scores and systolic blood pressure control: a SPRINT baseline data study. J Am Soc Hypertens (2016) 0.75
Blood pressure control in type 2 diabetic patients. Cardiovasc Diabetol (2017) 0.75
"They're younger… it's harder." Primary providers' perspectives on hypertension management in young adults: a multicenter qualitative study. BMC Res Notes (2017) 0.75
Ambulatory Blood Pressure Monitoring: A Complementary Strategy for Hypertension Diagnosis and Management in Low-Income and Middle-Income Countries. Cardiol Clin (2017) 0.75
The need for noninvasive methods to monitor hemodynamics in hypertension therapy. Hypertens Res (2016) 0.75
Help seeking behavior and onset-to-alarm time in patients with acute stroke: sub-study of the preventive antibiotics in stroke study. BMC Neurol (2016) 0.75
Memory is preserved in older adults taking AT1 receptor blockers. Alzheimers Res Ther (2017) 0.75
Systolic peak foot-to-apex time interval, a novel oscillometric technique for systolic blood pressure measurement. J Hypertens (2017) 0.75
Assessment of Blood Pressure Control among Hypertensive Patients in Southwest Ethiopia. PLoS One (2016) 0.75
Free versus Fixed Combination Antihypertensive Therapy for Essential Arterial Hypertension: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.75
Detecting prediabetes among Hispanics/Latinos from diverse heritage groups: Does the test matter? Findings from the Hispanic Community Health Study/Study of Latinos. Prev Med (2016) 0.75
Chinese herbal medicine for the treatment of primary hypertension: a methodology overview of systematic reviews. Syst Rev (2016) 0.75
Put pressure worldwide on blood pressure control. J Thorac Dis (2016) 0.75
Can I get a guideline to help me interpret treatment guidelines? Can J Hosp Pharm (2014) 0.75
[Not Available]. Can J Hosp Pharm (2014) 0.75
"Hypertension guidelines: good-bye to confusion and welcome to clarity". Indian Heart J (2015) 0.75
What should the target blood pressure goals be? Arch Med Sci (2016) 0.75
Dual inhibitory action on aldosterone by combined angiotensin receptor antagonism and neprilysin inhibition. Hypertens Res (2016) 0.75
Potential beneficial impact of angiotensin receptor blockers on arterial stiffness in hypertension. J Thorac Dis (2016) 0.75
Reducing effect of aerobic exercise on blood pressure of essential hypertensive patients: A meta-analysis. Medicine (Baltimore) (2017) 0.75
Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study. Drug Des Devel Ther (2016) 0.75
Vascular Disease in Young Indians (20-40 years): Role of Hypertension. J Clin Diagn Res (2016) 0.75
Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure. Vasc Health Risk Manag (2016) 0.75
Electrocardiographic detection of hypertensive left atrial enlargement in the presence of obesity: re-calibration against cardiac magnetic resonance. J Hum Hypertens (2016) 0.75
Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines. Clin Interv Aging (2015) 0.75
Effects of mineralocorticoid receptor antagonists in patients with hypertension and diabetes mellitus: a systematic review and meta-analysis. J Hum Hypertens (2015) 0.75
Azilsartan as a Potent Antihypertensive Drug with Possible Pleiotropic Cardiometabolic Effects: A Review Study. Front Pharmacol (2016) 0.75
The use of Piper sarmentosum leaves aqueous extract (Kadukmy™) as antihypertensive agent in spontaneous hypertensive rats. BMC Complement Altern Med (2015) 0.75
Cytochrome P450 and P-Glycoprotein-Mediated Interactions Involving African Herbs Indicated for Common Noncommunicable Diseases. Evid Based Complement Alternat Med (2017) 0.75
Developing consensus measures for global programs: lessons from the Global Alliance for Chronic Diseases Hypertension research program. Global Health (2017) 0.75
Pharmacokinetic Parameters and Over-Responsiveness of Iranian Population to Propranolol. Adv Pharm Bull (2017) 0.75
Blood Pressure Targets: Will We Reach Definite Figures? I Currently Have Mine. Arq Bras Cardiol (2017) 0.75
Profiles of lipids, blood pressure and weight changes among premenopausal Chinese breast cancer patients after adjuvant chemotherapy. BMC Womens Health (2017) 0.75
Alcohol's Effects on the Cardiovascular System. Alcohol Res (2017) 0.75
[Antihypertensive therapy in diabetes mellitus : Guidelines of the Austrian Diabetes Association 2016]. Wien Klin Wochenschr (2016) 0.75
What factors influence the average length of stay among stroke patients in a Nigerian tertiary hospital? Pan Afr Med J (2017) 0.75
Diagnosis, Prevalence, Awareness, Treatment, Prevention, and Control of Hypertension in Cameroon: Protocol for a Systematic Review and Meta-Analysis of Clinic-Based and Community-Based Studies. JMIR Res Protoc (2017) 0.75
Novel Index of Maladaptive Myocardial Remodeling in Hypertension. Circ Cardiovasc Imaging (2017) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet (2002) 23.18
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
A controlled trial of renal denervation for resistant hypertension. N Engl J Med (2014) 14.22
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med (2008) 11.61
Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med (2013) 11.10
The origin of the Haitian cholera outbreak strain. N Engl J Med (2010) 9.85
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med (2013) 8.74
Severe hypoglycemia and risks of vascular events and death. N Engl J Med (2010) 8.54
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol (2003) 7.79
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med (2013) 7.54
FGF23 induces left ventricular hypertrophy. J Clin Invest (2011) 7.22
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. Lancet (2012) 6.69
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet (2010) 6.23
Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors. N Engl J Med (2014) 5.93
Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the american heart association. Hypertension (2013) 5.88
The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol (2010) 5.54
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47
Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol (2008) 5.40
Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet (2007) 5.21
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet (2012) 5.10
Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA (2010) 5.06
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int (2011) 4.74
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation (2006) 4.61
Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis. J Am Coll Cardiol (2012) 4.56
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol (2009) 4.43
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care (2007) 4.30
Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation (2008) 4.29
European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens (2013) 4.28
Antihypertensive treatments obscure familial contributions to blood pressure variation. Hypertension (2003) 4.19
Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol (2009) 4.16
Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med (2003) 4.08
Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90
Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension (2006) 3.89
Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis. Ann Intern Med (2014) 3.81
Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med (2003) 3.78
Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA (2003) 3.71
Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med (2008) 3.71
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA (2004) 3.68
Mechanisms of hypertension associated with BAY 43-9006. J Clin Oncol (2006) 3.59
Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab (2004) 3.54
Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med (2005) 3.44
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Kidney Int (2013) 3.42
Systolic pressure is all that matters. Lancet (2008) 3.42
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol (2005) 3.27
Endothelial dysfunction. J Am Soc Nephrol (2004) 3.18
NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care (2008) 3.07
Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension (2006) 3.02
Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med (2003) 3.02
Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation (2005) 2.97
The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int (2004) 2.96
Masked hypertension in diabetes mellitus: treatment implications for clinical practice. Hypertension (2013) 2.89
Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2003) 2.86
Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens (2014) 2.82
Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem (2011) 2.82
Comparison of central pressure estimates obtained from SphygmoCor, Omron HEM-9000AI and carotid applanation tonometry. J Hypertens (2011) 2.76
Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care (2011) 2.75
Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial. Circulation (2011) 2.71